Anti-platelet drug useful

Patients with coronary stents require medication that inhibits platelet activity and prevents clotting. However, if patients need additional surgery that medication must be stopped several days in advance because it increases the risk of major bleeding during the operation. A new study tested an investigational drug that decreases clotting risk and also leaves the system quicker after it is stopped so surgery can be performed without a major delay. Catherine Dolf has more in this week's JAMA Report.

Related articles

• Drug Found To Help Lower Clotting Risk Prior To Cardiac Surgery (forbes.com)
• Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery (eurekalert.org)
• Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery (medicalxpress.com)
• Scripps-led study in JAMA shows new drug helps 'bridge' stent patients to cardiac surgery (eurekalert.org)
• Researchers identify factors associated with increased risk of blood clot within coronary stent (eurekalert.org)
• Genetic and Clinical Factors Linked to Stent Thrombosis (forbes.com)
• 'Bridging' Stent Patients To Cardiac Surgery (medicalnewstoday.com)
• Researchers find gene variants that cause stent thrombosis in people with coronary artery disease (medicalxpress.com)
• Q&A: Coronary stenting (bbc.co.uk)
• Heart Procedure - Angioplasty with Stent Implantation (Percutaneous Coronary Intervention - PCI) (allmedicaltourism.wordpress.com)